Skip to main content

Pharmacogenomic Data Segregation

Meaning

Pharmacogenomic data segregation is the systematic process of separating and isolating genetic information relevant to drug metabolism and response from the rest of a patient’s clinical or genomic data. This practice is implemented to ensure that highly sensitive information about an individual’s predicted reaction to endocrine therapies, such as Anastrozole or thyroid medication, is handled with specific, heightened security and privacy controls. Segregation allows for targeted access and use, limiting the exposure of this predictive genetic data while still enabling personalized medicine decisions.